VOLUME 93 ISSUE 5
July 2008
Symposium: U.S. Food and Drug Regulation in its First Century and Beyond
Articles
The Little Agency that Could (Act with Indifference to Constitutional and Statutory Strictures)
Lars Noah
Dirty Dancing - The FDA Stumbles with the Chevron Two-Step: A Response to Professor Noah
Gary Lawson
Losing Deference in the FDA's Second Century: Judicial Review, Politics, and a Diminished Legacy of Expertise
James T. O'Reilly
The FDA and Deference Lost: A Self-Inflicted Wound or the Product of a Wounded Agency? A Response to Professor O'Reilly
David C. Vladeck
FDA Regulatory Compliance Reconsidered
Carl Tobias
Greater and Lesser Powers of Tort Reform: The Primary Jurisdiction Doctrine and State-Law Claims Concerning FDA-Approved Products
Catherine T. Struve
Drug Review "Behind the Curtain": A Response to Professor Struve
James T. O'Reilly
Food, Drugs, and Droods: A Historical Consideration of Definitions and Categories in American Food and Drug Law
Lewis A. Grossman
